Folate Receptor Alpha Targeted Therapies - Exciting Advancements in Oncological R&D Revealed in Comprehensive Pipeline Review
December 14, 2023 05:28 ET
|
Research and Markets
Dublin, Dec. 14, 2023 (GLOBE NEWSWIRE) -- The "Folate Receptor alpha (FRa) Targeted Therapy Pipeline Review" report has been added to ResearchAndMarkets.com's offering. This pipeline review...
Global CD19 Antibody Market Projected to Exceed $10 Billion by 2028, Driven by Promising Pipeline of Therapies
November 09, 2023 05:58 ET
|
Research and Markets
Dublin, Nov. 09, 2023 (GLOBE NEWSWIRE) -- The "Global CD19 Antibody Market & Clinical Pipeline Outlook 2028" report has been added to ResearchAndMarkets.com's offering. The global CD19...
The Global Market for Bispecific Antibody Therapeutics Contract Manufacturing 2023-2030: Driven by Demand for Innovative Therapies and Promising Results Seen in Clinical Development
November 06, 2023 09:04 ET
|
Research and Markets
Dublin, Nov. 06, 2023 (GLOBE NEWSWIRE) -- The "Global Bispecific Antibody Therapeutics Contract Manufacturing Market 2023-2030" report has been added to ResearchAndMarkets.com's offering. The...
China Bispecific Antibodies Market and Clinical Pipeline Insight Report 2023-2028: Akeso are Leading the Way and Gaining Global Recognition for their Innovative Clinical Candidates
November 06, 2023 04:23 ET
|
Research and Markets
Dublin, Nov. 06, 2023 (GLOBE NEWSWIRE) -- The "China Bispecific Antibodies Market and Clinical Pipeline Insight 2028" drug pipelines has been added to ResearchAndMarkets.com's offering. The...
Global CD19 Antibody Market Set to Surpass $10 Billion by 2028: A Revolutionary Era in Immunotherapy
November 03, 2023 07:43 ET
|
Research and Markets
Dublin, Nov. 03, 2023 (GLOBE NEWSWIRE) -- The "Global CD19 Antibody Market and Clinical Pipeline Outlook 2028" report has been added to ResearchAndMarkets.com's offering. The global CD19 Antibody...
United States Bispecific Antibodies Market & Clinical Pipeline Research Report 2023: Potential Market Opportunity of $15 Billion By 2028 - Dosage, Price and Sales Insights
October 16, 2023 07:03 ET
|
Research and Markets
Dublin, Oct. 16, 2023 (GLOBE NEWSWIRE) -- The "US Bispecific Antibodies Market & Clinical Pipeline Insight 2028" drug pipelines has been added to ResearchAndMarkets.com's offering. The US...
TIGIT Inhibitors Revolutionize Immune System Control: A Comprehensive Analysis of Clinical Trials and Market Dynamics
September 06, 2023 10:34 ET
|
Research and Markets
Dublin, Sept. 06, 2023 (GLOBE NEWSWIRE) -- The "Anti TIGIT Antibody Market Opportunity and Clinical Trials Insight 2024" report has been added to ResearchAndMarkets.com's offering. The report...
Global Bispecific Antibodies Market Clinical Trials Antibody Sales Forecast 2028
December 08, 2022 02:36 ET
|
KuicK Research
Delhi, Dec. 08, 2022 (GLOBE NEWSWIRE) -- "Global Bispecific Antibody Market Opportunity, Drug Sales, Price and Clinical Trials Insight 2028" Report Highlights: Global Bispecific Antibody...
Discovery of Bispecific Antibodies and Immune Checkpoint Inhibitors Which Kill Glioblastoma and Block the Metastasis of Malignant Melanoma Cells to the Lung By Over 90% Announced by Ocean Biomedical and Aesther Healthcare (NASDAQ: AEHA)
September 06, 2022 07:45 ET
|
Aesther Healthcare Acquisition Corp.
• Ocean Biomedical will be a wholly owned subsidiary of Aesther Healthcare Acquisition Corp. and will change its name to Ocean Biomedical, Inc., expected to be listed on NASDAQ under the symbol,...
F-star Therapeutics Appoints James Sandy as Chief Development Officer
March 01, 2022 08:00 ET
|
F-star Therapeutics, Inc.
CAMBRIDGE, United Kingdom and CAMBRIDGE, Mass., March 01, 2022 (GLOBE NEWSWIRE) -- F-star Therapeutics, Inc. (NASDAQ: FSTX), a clinical-stage biopharmaceutical company dedicated to developing next...